Switch to:

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Share Ownership Details
Cole G BradleyCOO2017-01-10Sell5,00035,882$29.22146.1-5.6135,882 (Direct)
Popovits Kimberly JPresident and CEO
(Click for the stocks that their CEOs have bought)
2016-12-05Sell5,000289,594$30.02150.1-8.1359,620 (Direct)
12,298 (Held by UBS for Benefit of Kimberly Popovits)
16,825 (Held in trust for the benefit of Ms. Popovits' son, of which Ms. Popovits is trustee.)
200,851 (Held by the Popovits 2010 Trust)
Leber LauraChief Communication Officer2016-11-21Sell7,06814,331$31.73224.27-13.0814,331 (Direct)
Shak StevenChief Scientific Officer2016-11-10Sell5,000327,207$31.71158.55-13.02327,207 (Direct)
Cole G BradleyCOO2016-11-08Sell5,00035,426$29.68148.4-7.0835,426 (Direct)
Popovits Kimberly JPresident and CEO2016-11-03Sell5,313289,594$28.88153.44-4.559,620 (Direct)
200,851 (Held by the Popovits 2010 Trust)
12,298 (Held by UBS for Benefit of Kimberly Popovits)
16,825 (Held in trust for the benefit of Ms. Popovits' son, of which Ms. Popovits is trustee.)
Shak StevenChief Scientific Officer2016-10-11Sell5,000327,207$30.39151.95-9.25327,207 (Direct)
Cole G BradleyCOO2016-10-10Sell8,29035,426$30.59253.59-9.8435,426 (Direct)
Vaughn James JChief Commercial Officer2016-10-06Sell3,00026,079$29.6889.04-7.0826,079 (Direct)
Shak StevenChief Scientific Officer2016-09-13Sell5,000327,207$26.83134.152.8327,207 (Direct)
Cole G BradleyCOO2016-09-06Sell4,00035,426$27.41109.640.6235,426 (Direct)
Shak StevenChief Scientific Officer2016-08-23Sell5,000327,207$27.24136.21.25327,207 (Direct)
BAKER FELIXDirector, 10% Owner2016-08-15Buy100,00011,841,478$27.0227022.07
318,623 (See footnote(,))
11,348,958 (See footnote(,,))
173,897 (See footnote(F1,))
Cole G BradleyCOO2016-08-11Sell5,00035,426$28.87144.35-4.4735,426 (Direct)
Vaughn James JChief Commercial Officer2016-08-08Sell3,00029,079$28.7486.22-4.0429,079 (Direct)
Shak StevenChief Scientific Officer2016-07-19Sell5,000327,207$27.42137.10.58327,207 (Direct)
Cole G BradleyCOO2016-07-06Sell5,00035,426$26.64133.23.5335,426 (Direct)
Shak StevenChief Scientific Officer2016-06-21Sell5,000327,207$25.77128.857.02327,207 (Direct)
Cole G BradleyCOO2016-06-09Sell5,00035,426$26.62133.13.6135,426 (Direct)
Vaughn James JChief Commercial Officer2016-06-06Sell1,99732,079$2855.92-1.532,079 (Direct)
Cole G BradleyCOO2016-05-16Sell5,00034,970$27.6138-0.0734,970 (Direct)
Febbo Phillip G.Chief Medical Officer2016-05-10Sell6,32415,013$27.2172.011.415,013 (Direct)
Vaughn James JChief Commercial Officer2016-05-09Sell2,00031,255$2856-1.531,255 (Direct)
Shak StevenChief Scientific Officer2016-05-04Sell10,000326,383$25.43254.38.45326,383 (Direct)
Vaughn James JChief Commercial Officer2016-02-09Sell324,076$280.08-1.524,076 (Direct)
LIVINGSTON RANDALL SDirector2016-01-13Sell1,2506,149$32.1440.18-14.196,149 (Direct)
Cole G BradleyCOO2016-01-12Sell4,00027,428$31.69126.76-12.9727,428 (Direct)
Vaughn James JChief Commercial Officer2016-01-07Sell2,00024,076$33.6367.26-17.9924,076 (Direct)
Cole G BradleyCOO2015-12-08Sell4,00027,428$29.26117.04-5.7427,428 (Direct)
Leber LauraChief Communication Officer2015-12-07Sell4,20012,959$29.33123.19-5.9712,959 (Direct)
Vaughn James JChief Commercial Officer2015-12-07Sell2,00024,076$29.3358.66-5.9724,076 (Direct)
Cole G BradleyCOO2015-11-10Sell4,00030,326$26.03104.125.9530,326 (Direct)
Cole G BradleyCOO2015-09-09Sell9,66430,326$25.35244.988.830,326 (Direct)
Cole G BradleyCOO2015-07-07Sell4,00030,326$27.53110.120.1830,326 (Direct)
Cole G BradleyCOO2015-06-09Sell4,00030,326$26.24104.965.1130,326 (Direct)
Cole G BradleyCOO2015-05-12Sell4,00029,658$27.54110.160.1529,658 (Direct)
Popovits Kimberly JPresident and CEO2015-04-13Sell3,000203,001$31.2893.84-11.83Link
Cole G BradleyCOO2015-04-07Sell4,00029,658$30.44121.76-9.429,658 (Direct)
Popovits Kimberly JPresident and CEO2015-03-12Sell3,000204,101$31.9195.73-13.57Link
Cole G BradleyCOO2015-03-10Sell4,00029,658$31.84127.36-13.3829,658 (Direct)
Popovits Kimberly JPresident and CEO2015-02-12Sell3,000204,601$29.8689.58-7.64Link
Cole G BradleyCOO2015-02-10Sell4,00021,645$31.37125.48-12.0821,645 (Direct)
LIVINGSTON RANDALL SDirector2015-02-02Sell1,0006,149$31.9331.93-13.626,149 (Direct)
Popovits Kimberly JPresident and CEO2015-01-12Sell3,000204,601$33.46100.38-17.57Link
Popovits Kimberly JPresident and CEO2014-12-11Sell3,000204,601$32.9998.97-16.4Link
Cole G BradleyCOO2014-12-08Sell4,33621,645$32.52141.01-15.1921,645 (Direct)
Popovits Kimberly JPresident and CEO2014-11-12Sell4,300205,201$34.82149.73-20.79Link
Cole G BradleyCOO2014-11-10Sell4,00022,891$35.35141.4-21.9822,891 (Direct)
LIVINGSTON RANDALL SDirector2014-11-03Sell3,0006,149$36.24108.72-23.96,149 (Direct)
Popovits Kimberly JPresident and CEO2014-10-13Sell3,000205,201$30.7892.34-10.4Link
Cole G BradleyCOO2014-10-08Sell4,00022,891$28.77115.08-4.1422,891 (Direct)
Popovits Kimberly JPresident and CEO2014-09-11Sell3,000205,201$29.8289.46-7.51Link
Cole G BradleyCOO2014-09-08Sell4,70022,891$30.09141.42-8.3422,891 (Direct)
Shak StevenEVP of R&D2014-08-14Sell13,348312,298$27.36365.20.8312,298 (Direct)
Popovits Kimberly JPresident and CEO2014-08-12Sell3,000205,201$26.0778.215.79Link
Popovits Kimberly JPresident and CEO2014-07-14Sell3,000205,201$26.5979.773.72Link
Cole G BradleyCOO2014-07-08Sell2,30022,891$27.0562.221.9622,891 (Direct)
Shak StevenEVP of R&D2014-07-01Sell7,000312,298$271892.15312,298 (Direct)
Shak StevenEVP of R&D2014-06-12Sell7,000312,298$26.73187.113.18312,298 (Direct)
Popovits Kimberly JPresident and CEO2014-06-12Sell3,000271,289$26.178.35.67Link
Schorno Dean LCFO2014-06-10Sell4,00030,673$27.62110.48-0.1424,524 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2014-06-09Sell2,33722,891$27.2963.781.0622,891 (Direct)
Popovits Kimberly JPresident and CEO2014-05-12Sell3,000270,579$26.5479.623.92Link
Schorno Dean LCFO2014-05-09Sell4,00029,963$25.09100.369.9223,814 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Shak StevenEVP of R&D2014-04-14Sell7,000311,588$26.25183.755.07311,588 (Direct)
Cole G BradleyCOO2014-04-08Sell3,00022,226$27812.1522,226 (Direct)
Shak StevenEVP of R&D2014-03-14Sell7,000311,588$28.36198.52-2.75311,588 (Direct)
Cole G BradleyCOO2014-03-10Sell3,00022,226$27.7683.28-0.6522,226 (Direct)
HIBBS KATHY LSVP & General Counsel2014-02-18Sell1,31215,787$27.8836.58-1.0815,787 (Direct)
Shak StevenEVP of R&D2014-02-14Sell7,000311,588$27.38191.660.73311,588 (Direct)
Cole G BradleyCOO2014-02-10Sell3,00024,789$27812.1524,789 (Direct)
Shak StevenEVP of R&D2014-01-15Sell7,000308,283$31.51220.57-12.47308,283 (Direct)
Popovits Kimberly JPresident and CEO2014-01-13Sell2,500261,190$3075-8.07Link
Cole G BradleyCOO2014-01-08Sell3,00018,369$28.1784.51-2.0918,369 (Direct)
Shak StevenEVP of R&D & CMO2013-12-17Sell14,000308,283$29.57413.98-6.73308,283 (Direct)
Popovits Kimberly JPresident and CEO2013-12-12Sell2,5000$30.6876.7-10.1Link
Schorno Dean LCFO2013-12-09Sell3,00027,706$33.2599.75-17.0521,557 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2013-12-02Sell1,0006,149$34.9234.92-21.026,149 (Direct)
Popovits Kimberly JPresident and CEO2013-11-13Sell5,0000$34.58172.9-20.24Link
Schorno Dean LCFO2013-11-08Sell3,00027,585$33.36100.08-17.3321,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-11-06Sell2,86818,135$31.3890-12.1118,135 (Direct)
Shak StevenEVP of R&D & CMO2013-10-15Sell5,000308,283$29.67148.35-7.04308,283 (Direct)
Popovits Kimberly JPresident and CEO2013-10-10Sell2,5000$3075-8.07Link
Cole G BradleyCOO2013-10-09Sell2,50018,135$29.9574.88-7.9118,135 (Direct)
Shak StevenEVP of R&D & CMO2013-09-18Sell5,000313,283$33.73168.65-18.23313,283 (Direct)
Popovits Kimberly JPresident and CEO2013-09-12Sell2,5000$34.3185.78-19.62Link
Cole G BradleyCOO2013-09-09Sell2,50018,135$32.5381.33-15.2218,135 (Direct)
Schorno Dean LCFO2013-09-06Sell4,00027,585$32.9131.6-16.1721,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2013-09-03Sell1,0006,149$31.4931.49-12.426,149 (Direct)
Shak StevenEVP of R&D & CMO2013-08-14Sell5,000318,283$32.98164.9-16.37318,283 (Direct)
Popovits Kimberly JPresident and CEO2013-08-12Sell2,5000$33.0382.58-16.5Link
Schorno Dean LCFO2013-08-09Sell4,00027,585$33.15132.6-16.821,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2013-08-09Sell4,00027,585$33.15132.6-16.821,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-08-07Sell2,50019,135$33.6684.15-18.0619,135 (Direct)
Shak StevenEVP of R&D & CMO2013-07-23Sell5,000318,283$35.33176.65-21.94318,283 (Direct)
Popovits Kimberly JPresident and CEO2013-07-12Sell5,0000$34.61173.05-20.31Link
Schorno Dean LCFO2013-07-09Sell4,00023,985$33.81135.24-18.4317,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2013-07-09Sell4,00023,985$33.81135.24-18.4317,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-07-08Sell2,50013,135$33.3383.33-17.2513,135 (Direct)
Shak StevenEVP of R&D & CMO2013-06-18Sell5,000323,283$33.52167.6-17.72323,283 (Direct)
Popovits Kimberly JPresident and CEO2013-06-12Sell5,0000$35.68178.4-22.7Link
Schorno Dean LCFO2013-06-10Sell4,00023,985$35.88143.52-23.1317,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-06-05Sell2,50013,135$36.4791.18-24.3813,135 (Direct)
BAKER FELIXDirector, 10% Owner2013-06-05Buy381,43213,288,253$36.1613792.58-23.73
1,730,777 (See Footnote)
11,241,654 (See Footnotes(F7,F14,F15))
301,215 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
BAKER FELIXDirector, 10% Owner2013-06-03Buy179,58312,906,821$36.716592.49-24.87
1,690,226 (See Footnote)
10,909,066 (See Footnotes(F7,F14,F15))
292,922 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
LIVINGSTON RANDALL SDirector2013-06-03Sell1,0006,149$36.436.4-24.236,149 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-29Buy121,26612,727,238$36.894473.5-25.24
1,671,081 (See Footnote)
10,752,532 (See Footnotes(F7,F14,F15))
289,018 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
BAKER FELIXDirector, 10% Owner2013-05-24Buy79,41714,257,273$36.932932.87-25.32
1,651,301 (See Footnote)
10,646,920 (See Footnotes(F7,F17,F18))
286,384 (See Footnotes(F9,F17,F18))
1,658,061 (See Footnotes(F5,F17,F18))
14,607 (See Footnote(F9,F17,F18))
HIBBS KATHY LSVP & General Counsel2013-05-22Sell1,0007,087$37.4837.48-26.417,087 (Direct)
Shak StevenEVP of R&D & CMO2013-05-21Sell5,000327,380$37.19185.95-25.84327,380 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-16Buy71,43912,526,555$36.452603.95-24.33
1,649,473 (See Footnote)
10,577,816 (See Footnotes(F7,F14,F15))
284,659 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
LIVINGSTON RANDALL SDirector2013-05-15Sell1,3376,149$35.8347.9-23.036,149 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-14Buy240,42614,093,759$34.348256.23-19.69
1,638,643 (See Footnote)
10,515,769 (See Footnotes(F7,F17,F18))
283,112 (See Footnotes(F9,F17,F18))
1,641,628 (See Footnotes(F5,F17,F18))
14,607 (See Footnote(F9,F17,F18))
HIBBS KATHY LSVP & General Counsel2013-05-13Sell1,2507,087$34.4243.03-19.877,087 (Direct)
Popovits Kimberly JPresident and CEO2013-05-13Sell5,0000$34.7173.5-20.52Link
Schorno Dean LCFO2013-05-09Sell4,00023,241$36.02144.08-23.4317,092 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-05-08Sell2,50012,540$35.9989.98-23.3712,540 (Direct)
Popovits Kimberly JPresident and CEO2013-04-23Sell2,5000$3075-8.07Link
Cole G BradleyCOO2013-04-03Sell2,50012,540$27.7969.48-0.7612,540 (Direct)
Cole G BradleyCOO2013-03-06Sell2,50012,540$28.5771.43-3.4712,540 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-21Buy49,08512,211,834$27.781363.58-0.72
1,614,513 (See Footnote)
10,306,239 (See Footnotes(F7,F14,F15))
277,189 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
HIBBS KATHY LSVP & General Counsel2013-02-20Sell2,7167,087$28.1376.4-1.967,087 (Direct)
MYERS WOODROW A JRDirector2013-02-14Sell41,2502,891$28.41171.5-2.892,891 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-14Buy52,00012,162,749$28.481480.96-3.16
1,609,152 (See Footnote)
10,263,580 (See Footnotes(F7,F14,F15))
276,124 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
BAKER FELIXDirector, 10% Owner2013-02-11Buy116,36012,110,749$28.153275.53-2.02
1,603,265 (See Footnote)
10,218,600 (See Footnotes(F7,F14,F15))
274,991 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
Cole G BradleyCOO2013-02-06Sell2,50014,085$28.0370.08-1.6114,085 (Direct)
LIVINGSTON RANDALL SDirector2013-01-28Sell2,0006,149$28.7757.54-4.146,149 (Direct)
Schorno Dean LCFO2013-01-09Sell2,62523,504$2873.5-1.517,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-01-09Sell2,50014,085$27.8869.7-1.0814,085 (Direct)
Shak StevenEVP of R&D & CMO2012-12-18Sell5,000333,768$27.74138.7-0.58333,768 (Direct)
Popovits Kimberly JPresident and CEO2012-12-13Sell5,0000$27.79138.95-0.76Link
Schorno Dean LCFO2012-12-11Sell3,00023,504$2884-1.517,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2012-11-26Sell2,0006,149$27.8455.68-0.936,149 (Direct)
BAKER FELIXDirector, 10% Owner2012-11-21Buy229,30012,263,857$26.836152.122.8288 (Direct)
271,800 (See Footnote)
1,589,551 (See Footnotes(F5,F14,F15))
10,117,174 (See Footnotes(F7,F14,F15))
271,806 (See Footnotes(F9,F14,F15))
13,238 (See Footnote(F9,F14,F15))
Shak StevenEVP of R&D & CMO2012-11-20Sell5,000338,768$26.94134.72.38338,768 (Direct)
COLELLA SAMUEL DDirector2012-11-20Sell30,61636,437$26.89823.262.5736,437 (Direct)
0 (Versant Venture Capital I, L.P.)
0 (Versant Side Fund I, L.P.)
0 (Versant Affiliates Fund I-A, L.P.)
0 (Versant Affiliates Fund I-B, L.P.)
BAKER FELIXDirector, 10% Owner2012-11-14Buy103,16713,526$27.322818.520.95288 (Direct)
13,238 (See Footnote)
Popovits Kimberly JPresident and CEO2012-11-14Sell5,0000$27.24136.21.25Link
BAKER FELIXDirector, 10% Owner2012-11-13Buy823,77213,526$27.8122909.1-0.83288 (Direct)
13,238 (See Footnote)
Schorno Dean LCFO2012-11-12Sell3,00023,504$2884-1.517,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2012-11-08Sell2,50014,085$28.6271.55-3.6314,085 (Direct)
Popovits Kimberly JPresident and CEO2012-10-16Sell10,0000$33.08330.8-16.63Link
Shak StevenEVP of R&D & CMO2012-10-16Sell5,000343,768$35.25176.25-21.76343,768 (Direct)
Schorno Dean LCFO2012-10-12Sell3,00023,504$33.79101.37-18.3817,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
HIBBS KATHY LSVP & General Counsel2012-10-11Sell1,25011,367$33.7842.23-18.3511,367 (Direct)
Cole G BradleyCOO2012-10-09Sell2,50014,085$34.887-20.7514,085 (Direct)
Shak StevenEVP of R&D & CMO2012-09-18Sell5,000348,768$33.76168.8-18.31348,768 (Direct)
Popovits Kimberly JPresident and CEO2012-09-13Sell5,0000$31.69158.45-12.97Link
Cole G BradleyCOO2012-09-06Sell2,50014,085$35.0187.53-21.2214,085 (Direct)
MYERS WOODROW A JRDirector2012-08-21Sell16,5002,236$35.2580.8-21.652,236 (Direct)
Shak StevenEVP of R&D & CMO2012-08-20Sell5,000353,768$34.99174.95-21.18353,768 (Direct)
Popovits Kimberly JPresident and CEO2012-08-13Sell10,0000$34.72347.2-20.56Link
Cole G BradleyCOO2012-08-08Sell2,50014,085$30.4976.23-9.5414,085 (Direct)
LIVINGSTON RANDALL SDirector2012-07-26Sell2,0006,149$35.971.8-23.186,149 (Direct)
Shak StevenChief Medical Officer2012-07-24Sell5,000358,768$34.24171.2-19.45358,768 (Direct)
Popovits Kimberly JPresident and CEO2012-07-13Sell7,1000$34.76246.8-20.66Link
Scott Randal WCEO, InVitae Corporation*2012-07-11Sell30,0000$35.391061.7-22.07Link
Cole G BradleyCOO2012-07-05Sell2,50014,085$35.9589.88-23.2814,085 (Direct)
Shak StevenChief Medical Officer2012-06-25Sell5,000363,768$33.25166.25-17.05363,768 (Direct)
Popovits Kimberly JPresident and CEO2012-06-13Sell5,0000$33.36166.8-17.33Link
Popovits Kimberly JPresident and CEO2012-06-13Sell5,0000$33.36166.8-17.33Link
Scott Randal WCEO, InVitae Corporation*2012-06-12Sell30,0000$33.541006.2-17.77Link
Cole G BradleyCOO2012-06-06Sell2,50013,507$33.9784.93-18.8113,507 (Direct)
Shak StevenChief Medical Officer2012-05-24Sell5,000367,849$33.8169-18.4367,849 (Direct)
BAKER JULIANDirector, 10% Owner2012-05-22Buy167,4061,488,539$32.265400.52-14.51
1,488,539 (See Footnote)
COLELLA SAMUEL DDirector2012-05-18Sell26,294664,113$33.03868.49-16.526,891 (Direct)
582,174 (Versant Venture Capital I, L.P.)
11,210 (Versant Side Fund I, L.P.)
13,222 (Colella Family Partners, L.P.)
10,414 (Versant Affiliates Fund I-A, L.P.)
20,202 (Versant Affiliates Fund I-B, L.P.)
BAKER JULIANDirector, 10% Owner2012-05-16Buy376,0591,488,539$33.8812740.88-18.6
1,488,539 (See Footnote)
Popovits Kimberly JPresident and CEO2012-05-16Sell10,0000$34.23342.3-19.43Link
Schorno Dean LCFO2012-05-15Sell1,00023,504$33.6933.69-18.1417,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
BAKER JULIANDirector, 10% Owner2012-05-11Buy114,8881,488,539$29.963442.04-7.94
1,488,539 (See Footnote)
Scott Randal WCEO, InVitae Corporation*2012-05-11Sell30,0000$30.22906.6-8.74Link
Cole G BradleyCOO2012-05-09Sell2,50013,507$28.8772.18-4.4713,507 (Direct)
BAKER JULIANDirector, 10% Owner2012-05-08Buy195,70113,238$28.455567.69-3.06
13,238 (See Footnote)
LIVINGSTON RANDALL SDirector2012-04-26Sell2,0006,149$28.2156.42-2.236,149 (Direct)
Shak StevenChief Medical Officer2012-04-24Sell5,000372,849$27.93139.65-1.25372,849 (Direct)
Popovits Kimberly JPresident and CEO2012-04-23Sell5,0000$27.79138.95-0.76Link
Schorno Dean LCFO2012-04-16Sell1,00024,504$27.9827.98-1.4318,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WCEO, InVitae Corporation*2012-04-11Sell20,0000$28.59571.8-3.53Link
Cole G BradleyCOO2012-04-04Sell2,50013,507$30.2875.7-8.9213,507 (Direct)
Shak StevenChief Medical Officer2012-03-22Sell5,000377,849$30.08150.4-8.31377,849 (Direct)
Popovits Kimberly JPresident and CEO2012-03-22Sell5,0000$30.07150.35-8.28Link
Popovits Kimberly JPresident and CEO2012-03-22Sell5,0000$30.07150.35-8.28Link
Shak StevenChief Medical Officer2012-03-22Sell5,000377,849$30.08150.4-8.31377,849 (Direct)
Schorno Dean LCFO2012-03-15Sell1,00025,504$31.0831.08-11.2619,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WCEO, InVitae Corporation2012-03-13Sell30,0000$31.05931.5-11.18Link
Cole G BradleyCOO2012-03-08Sell2,50013,507$29.9474.85-7.8813,507 (Direct)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-03-08Buy4,5081,484,977$30.11135.74-8.4
1,484,977 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-03-08Buy1,099227,840$30.1133.09-8.4
227,840 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-03-08Buy41,5848,255,421$30.111252.09-8.4
8,255,421 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-03-05Buy261,7618,213,837$29.817803.1-7.48
8,213,837 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-03-05Buy6,923226,741$29.81206.37-7.48
226,741 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-03-05Buy31,3321,480,469$29.81934.01-7.48
1,480,469 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-29Buy6,476219,818$29.06188.19-5.09
219,818 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-29Buy245,0317,952,076$29.067120.6-5.09
7,952,076 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-29Buy29,7561,449,137$29.06864.71-5.09
1,449,137 (Through Partnership)
Popovits Kimberly JPresident and CEO2012-02-24Sell10,0000$28.5285-3.23Link
Shak StevenChief Medical Officer2012-02-23Sell5,000382,849$28.14140.7-1.99382,849 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-23Buy114,5187,707,045$28.063213.38-1.71
7,707,045 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-23Buy3,022213,342$28.0684.8-1.71
213,342 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-23Buy13,3321,419,381$28.06374.1-1.71
1,419,381 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-16Buy33,1851,406,049$29.34973.65-6
1,406,049 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-16Buy7,213210,320$29.37211.85-6.09
210,320 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-16Buy272,9097,592,527$29.378015.34-6.09
7,592,527 (Through Partnership)
Schorno Dean LCFO2012-02-15Sell1,00026,504$28.7628.76-4.120,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2012-02-15Sell75526,749$28.7621.71-4.120,600 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2012-02-10Sell20,0000$26.18523.65.35Link
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-10Buy417,9157,319,618$26.3611016.244.63
7,319,618 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-10Buy11,043203,107$26.36291.094.63
203,107 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-10Buy66,5831,372,864$26.361755.134.63
1,372,864 (Through Partnership)
Scott Randal WExecutive Chairman2012-02-10Sell20,0000$26.18523.65.35Link
Cole G BradleyCOO2012-02-08Sell2,50014,450$26.4766.184.1914,450 (Direct)
LIVINGSTON RANDALL SDirector2012-01-26Sell2,0006,149$27.5155.020.256,149 (Direct)
Popovits Kimberly JPresident and CEO2012-01-25Sell5,0000$26.42132.14.39Link
Popovits Kimberly JPresident and CEO2012-01-24Sell5,0000$26.62133.13.61Link
Shak StevenChief Medical Officer2012-01-24Sell5,000382,778$26.74133.73.14382,778 (Direct)
Schorno Dean LCFO2012-01-17Sell1,00024,049$2828-1.517,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2012-01-12Sell2,5007,750$27.5468.850.157,750 (Direct)
Scott Randal WExecutive Chairman2012-01-11Sell20,0000$27.46549.20.44Link
Shak StevenChief Medical Officer2011-12-22Sell5,000387,778$26.03130.155.95387,778 (Direct)
Scott Randal WExecutive Chairman2011-12-13Sell20,0000$27.29545.81.06Link
Cole G BradleyCOO2011-12-06Sell2,5007,750$28.5971.48-3.537,750 (Direct)
14159 capital (GP), LLCDirector, 10% Owner2011-12-05Buy3,152192,064$28.1288.63-1.92
192,064 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-12-05Buy45,9771,306,281$27.661271.72-0.29
1,306,281 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-12-05Buy117,7516,901,703$28.123311.16-1.92
6,901,703 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-23Buy5,5311,260,304$25.91143.316.45
1,260,304 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-23Buy5,750188,912$25.94149.166.32
188,912 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-23Buy193,7396,783,952$25.915019.786.45
6,783,952 (Through Partnership)
Shak StevenChief Medical Officer2011-11-22Sell5,000392,778$26.07130.355.79392,778 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-16Buy64,5976,590,213$27.711789.98-0.47
6,590,213 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-16Buy2,550183,162$27.7170.66-0.47
183,162 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-16Buy4581,254,773$27.3512.530.84
1,254,773 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-14Buy10,106180,612$27.23275.191.29
180,612 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-14Buy249,3756,525,616$27.236790.481.29
6,525,616 (Through Partnership)
Scott Randal WExecutive Chairman2011-11-11Sell20,0000$27.24544.81.25Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-09Buy5421,254,315$26.7914.522.95
1,254,315 (Through Partnership)
Cole G BradleyCOO2011-11-08Sell2,5007,750$26.666.53.687,750 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-07Buy209,5126,276,241$25.945434.746.32
6,276,241 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-07Buy8,847170,506$25.94229.496.32
170,506 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-03Buy1201,253,773$24.482.9412.66
1,253,773 (Through Partnership)
LIVINGSTON RANDALL SDirector2011-10-27Sell2,0006,149$22.0844.1624.916,149 (Direct)
Shak StevenChief Medical Officer2011-10-24Sell5,000392,778$21.76108.826.75392,778 (Direct)
Scott Randal WExecutive Chairman2011-10-11Sell20,0000$22.83456.620.81Link
Cole G BradleyCOO2011-10-06Sell5,0007,750$22.31111.5523.627,750 (Direct)
Scott Randal WExecutive Chairman2011-09-13Sell20,0000$20.81416.232.53Link
Cole G BradleyCOO2011-09-06Sell2,5007,750$22.0855.224.917,750 (Direct)
Shak StevenChief Medical Officer2011-08-24Sell5,000392,778$23.02115.119.81392,778 (Direct)
Scott Randal WExecutive Chairman2011-08-11Sell20,0000$24.44488.812.85Link
Cole G BradleyCOO2011-08-08Sell2,5007,750$25.2663.159.187,750 (Direct)
Cole G BradleyCOO2011-08-08Sell2,5007,750$25.2663.159.187,750 (Direct)
LIVINGSTON RANDALL SDirector2011-07-27Sell2,0006,149$26.4552.94.276,149 (Direct)
Shak StevenChief Medical Officer2011-07-25Sell5,000392,778$27.61138.05-0.11392,778 (Direct)
Scott Randal WExecutive Chairman2011-07-12Sell20,0001,503,444$27.36547.20.81,491,146 (Direct)
12,298 (By Morgan Stanley DW Inc. as Custodian for Randal W. Scott, IRA)
Cole G BradleyCOO2011-07-06Sell5,0007,750$27.74138.7-0.587,750 (Direct)
Shak StevenChief Medical Officer2011-06-23Sell5,000392,778$27.12135.61.7392,778 (Direct)
Schorno Dean LCFO2011-06-15Sell1,00025,049$25.9125.916.4518,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2011-06-13Sell20,0001,523,444$25.69513.87.361,511,146 (Direct)
12,298 (By Morgan Stanley DW Inc. as Custodian for Randal W. Scott, IRA)
Baker Bros. Capital (GP), LLCDirector, 10% Owner2011-06-09Buy119194,415$26.193.125.31
194,415 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-06-09Buy4,388161,659$26.19114.925.31
161,659 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-06-09Buy203,6526,059,449$26.25335.685.27
6,059,449 (Through Partnership)
Cole G BradleyCOO2011-06-06Sell2,5007,750$26.1865.455.357,750 (Direct)
14159 capital (GP), LLCDirector, 10% Owner2011-06-01Buy4,631157,271$27.34126.610.88
157,271 (Through Partnership)
Baker Bros. Capital (GP), LLCDirector, 10% Owner2011-06-01Buy112194,296$27.353.060.84
194,296 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-06-01Buy181,6935,855,797$27.354969.30.84
5,855,797 (Through Partnership)
Shak StevenChief Medical Officer2011-05-25Sell5,000392,778$25.55127.757.95392,778 (Direct)
Schorno Dean LCFO2011-05-12Sell1,00026,049$26.4826.484.1519,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2011-05-11Sell20,0000$26.66533.23.45Link
Cole G BradleyCOO2011-05-09Sell2,5007,750$25.9364.836.367,750 (Direct)
LIVINGSTON RANDALL SDirector2011-04-27Sell2,0000$26.0452.085.91Link
Shak StevenChief Medical Officer2011-04-25Sell5,0000$25.38126.98.67Link
Popovits Kimberly JPresident and CEO2011-04-15Sell8,0000$25.49203.928.2Link
Schorno Dean LCFO2011-04-14Sell1,0000$25.3225.328.93Link
Scott Randal WExecutive Chairman2011-04-12Sell20,0000$25.96519.26.24Link
Cole G BradleyCOO2011-04-06Sell5,0000$26.91134.552.49Link
Shak StevenChief Medical Officer2011-03-24Sell5,0000$24.45122.2512.8Link
Popovits Kimberly JPresident and CEO2011-03-15Sell8,0000$24.29194.3213.54Link
Schorno Dean LCFO2011-03-15Sell1,0000$23.7923.7915.93Link
Popovits Kimberly JPresident and CEO2011-03-15Sell8,0000$24.29194.3213.54Link
Scott Randal WExecutive Chairman2011-03-11Sell20,0000$25.62512.47.65Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-10Buy70,8560$26.031844.385.95Link
Cole G BradleyCOO2011-03-08Sell2,5000$25.2363.089.31Link
14159 capital (GP), LLCDirector, 10% Owner2011-03-08Buy9,6480$25.06241.7810.06Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-08Buy349,5660$25.068760.1210.06Link
COLELLA SAMUEL DDirector2011-03-03Sell34,3200$25.45873.448.37Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-02Buy160,3370$25.694119.067.36Link
14159 capital (GP), LLCDirector, 10% Owner2011-03-02Buy4,4260$25.69113.77.36Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-02-25Buy158,3550$23.393703.9217.91Link
14159 capital (GP), LLCDirector, 10% Owner2011-02-25Buy4,3700$23.39102.2117.91Link
Shak StevenChief Medical Officer2011-02-24Sell5,0000$23.27116.3518.52Link
Schorno Dean LCFO2011-02-15Sell1,0000$22.5122.5122.52Link
Popovits Kimberly JPresident and CEO2011-02-15Sell8,0000$22.51180.0822.52Link
Scott Randal WExecutive Chairman2011-02-11Sell20,0000$22.244424.23Link
Popovits Kimberly JPresident and CEO2011-01-18Sell8,0000$21.15169.230.4Link
Popovits Kimberly JPresident and CEO2011-01-18Sell8,000309,424$21.15169.230.4Link
Schorno Dean LCFO2011-01-13Sell1,27626,149$21.0626.8730.96Link
Scott Randal WExecutive Chairman2011-01-11Sell20,0001,642,410$21.73434.626.92Link
Cole G BradleyCOO2011-01-06Sell5,0001,000$22.13110.6524.63Link
Popovits Kimberly JPresident and CEO2010-12-16Sell8,000310,624$22.71181.6821.44Link
Scott Randal WExecutive Chairman2010-12-13Sell20,0001,696,410$22.46449.222.8Link
Cole G BradleyCOO & CFO2010-12-13Sell2,5001,000$22.6456.621.82Link
Popovits Kimberly JPresident and CEO2010-11-16Sell8,000310,624$17.514057.6Link
Cole G BradleyCOO & CFO2010-11-11Sell2,5001,000$18.0445.152.88Link
Scott Randal WExecutive Chairman2010-11-11Sell20,0001,666,410$18.27365.450.96Link
Scott Randal WExecutive Chairman2010-10-12Sell20,0001,686,410$13.9527997.71Link
Popovits Kimberly JPresident and CEO2010-09-15Sell7,734310,624$15.1116.7882.65Link
Scott Randal WExecutive Chairman2010-09-13Sell20,0001,706,410$14.87297.485.47Link
Cole G BradleyCOO & CFO2010-09-13Sell2,5001,000$15.0137.5383.74Link
14159 capital (GP), LLCDirector, 10% Owner2010-09-09Buy145134,196$14.812.1586.23Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-09-09Buy5,2614,934,990$14.8177.9286.23Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-09-02Buy65,4664,929,729$14.46946.6490.73Link
14159 capital (GP), LLCDirector, 10% Owner2010-09-02Buy1,807134,051$14.4626.1390.73Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-30Buy3,415132,244$14.3749.0791.93Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-30Buy123,7114,864,263$14.371777.7391.93Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-23Buy150,4694,740,552$14.522184.8189.94Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-23Buy4,153128,829$14.5260.389.94Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-18Buy530124,676$14.997.9483.99Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-18Buy19,1874,590,083$14.99287.6183.99Link
Popovits Kimberly JPresident and CEO2010-08-17Sell8,000288,116$15.07120.5683.01Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-13Buy2,924124,146$14.8543.4285.72Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-13Buy105,9104,570,896$14.851572.7685.72Link
Cole G BradleyCOO & CFO2010-08-12Sell2,5001,000$1537.583.87Link
Scott Randal WExecutive Chairman2010-08-11Sell20,0001,726,410$14.71294.287.49Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-10Buy164,2424,464,986$14.612399.5888.77Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-10Buy4,533121,222$14.6166.2388.77Link
Baker JoffreChief Scientific Officer2010-08-09Sell4,629163,088$14.7568.2886.98Link
Scott Randal WExecutive Chairman2010-07-13Sell20,0001,746,410$12.81256.2115.3Link
Baker JoffreChief Scientific Officer2010-07-07Sell4,629167,717$13.0560.41111.34Link
Scott Randal WExecutive Chairman2010-06-11Sell20,0001,766,410$14.1528394.91Link
Baker JoffreChief Scientific Officer2010-06-10Sell4,629172,346$14.0565.0496.3Link
Popovits Kimberly JPresident and CEO2010-05-17Sell8,000310,624$15.78126.2474.78Link
Cole G BradleyCOO & CFO2010-05-12Sell2,5001,000$15.8739.6873.79Link
Scott Randal WExecutive Chairman2010-05-11Sell20,0001,776,410$15.61312.276.68Link
Baker JoffreChief Scientific Officer2010-05-10Sell4,629176,975$15.5171.877.82Link
Scott Randal WExecutive Chairman2010-04-13Sell20,0001,796,410$16.87337.463.49Link
Cole G BradleyCOO & CFO2010-04-12Sell5,0001,000$16.984.563.2Link
Baker JoffreChief Scientific Officer2010-04-12Sell4,629181,604$16.8878.1463.39Link
Popovits Kimberly JPresident and CEO2010-03-16Sell20,000288,116$19.4538941.8Link
Scott Randal WExecutive Chairman2010-03-11Sell20,0001,800,646$19.338642.9Link
Cole G BradleyCOO & CFO2010-03-11Sell2,5001,000$19.3948.4842.24Link
COLELLA SAMUEL DDirector2010-03-10Sell106,70085,050$19.452075.3241.8Link
Baker JoffreChief Scientific Officer2010-03-08Sell4,629150,120$19.8391.7939.08Link
14159 capital (GP), LLCDirector, 10% Owner2010-02-19Buy3,645116,689$17.0562.1561.76Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-02-19Buy132,0704,300,744$17.052251.7961.76Link
Scott Randal WExecutive Chairman2010-02-11Sell20,0001,830,646$17.23344.660.07Link
Cole G BradleyCOO & CFO2010-02-11Sell2,5001,000$17.5143.7857.51Link
14159 capital (GP), LLCDirector, 10% Owner2010-02-10Buy9,437113,044$17.01160.5262.14Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-02-10Buy341,8544,168,674$17.015814.9462.14Link
Baker JoffreChief Scientific Officer2010-02-09Sell4,629145,491$17.1479.3460.91Link
Cole G BradleyCOO & CFO2010-01-12Sell5,0001,000$17.2586.2559.88Link
Baker JoffreChief Scientific Officer2010-01-11Sell4,629150,120$17.4780.8757.87Link
Shak StevenChief Medical Officer2009-12-21Sell5,000388,278$20.12100.637.08Link
Popovits Kimberly JPresident and CEO2009-12-15Sell5,000313,506$20.39101.9535.26Link
Cole G BradleyCOO & CFO2009-12-14Sell2,0001,000$20.4240.8435.06Link
Scott Randal WExecutive Chairman2009-12-11Sell12,0001,880,646$20.24242.8836.26Link
Baker JoffreChief Scientific Officer2009-12-08Sell4,629154,749$20.2693.7836.13Link
Popovits Kimberly JPresident and CEO2009-11-17Sell20,000318,506$19.21384.243.57Link
Cole G BradleyCOO & CFO2009-11-12Sell6653,000$20.0413.3337.62Link
Scott Randal WExecutive Chairman2009-11-11Sell12,0001,892,646$19.99239.8837.97Link
Baker JoffreChief Scientific Officer2009-11-10Sell4,629159,378$2092.5837.9Link
Shak StevenChief Medical Officer2009-10-20Sell5,000393,278$20.65103.2533.56Link
Popovits Kimberly JPresident and CEO2009-10-15Sell5,000338,506$20.42102.135.06Link
Scott Randal WExecutive Chairman2009-10-13Sell12,0001,904,646$20.66247.9233.49Link
Baker JoffreChief Scientific Officer2009-10-07Sell4,629164,007$21.179830.28Link
Shak StevenChief Medical Officer2009-09-22Sell5,000398,278$21.13105.6530.53Link
Popovits Kimberly JPresident and CEO2009-09-15Sell5,000343,506$20.73103.6533.04Link
Scott Randal WExecutive Chairman2009-09-11Sell12,0001,916,646$20.67248.0433.43Link
Baker JoffreChief Scientific Officer2009-09-04Sell4,629168,636$20.1293.1437.08Link
Shak StevenChief Medical Officer2009-08-25Sell5,000403,278$20.77103.8532.79Link
14159 capital (GP), LLCDirector, 10% Owner2009-08-17Buy1,839103,607$19.9836.7438.04Link
Baker Brothers Life Sciences CDirector, 10% Owner2009-08-17Buy66,6303,826,820$19.981331.2738.04Link
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-08-17Buy34194,184$19.980.6838.04Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2009-08-17Buy11,6571,253,653$19.98232.9138.04Link
Popovits Kimberly JPresident and CEO2009-08-17Sell5,000348,506$19.5397.6541.22Link
Cole G BradleyCOO & CFO2009-08-13Sell5,0003,000$2010037.9Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2009-08-12Buy15,8771,241,996$19.49309.4441.51Link
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-08-12Buy45194,150$19.50.8841.44Link
Baker Brothers Life Sciences CDirector, 10% Owner2009-08-12Buy90,7543,760,190$19.491768.841.51Link
14159 capital (GP), LLCDirector, 10% Owner2009-08-12Buy2,508101,768$19.4948.8841.51Link
Scott Randal WExecutive Chairman2009-08-11Sell12,0001,928,646$19.42233.0442.02Link
Baker JoffreChief Scientific Officer2009-08-10Sell4,629173,265$19.4890.1741.58Link
Baker JoffreChief Scientific Officer2009-07-08Sell4,629177,894$16.0174.1172.27
Baker JoffreChief Scientific Officer2009-07-08Sell4,629177,894$16.0174.1172.27
Scott Randal WExecutive Chairman2009-06-11Sell6,0001,940,646$18.27109.6250.96
Baker JoffreChief Scientific Officer2009-06-08Sell4,629182,523$17.6981.8955.91
Shak StevenChief Medical Officer2009-05-26Sell5,000408,278$199545.16
14159 capital (GP), LLCDirector, 10% Owner2009-05-21Buy1,10899,260$17.9719.9153.48
Baker / Tisch Capital (GP), LLDirector, 10% Owner2009-05-21Buy90194,161$17.971.6253.48
Baker Brothers Life Sciences CDirector, 10% Owner2009-05-21Buy39,7783,669,436$17.97714.8153.48
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-05-21Buy25194,105$17.970.4553.48
Popovits Kimberly JPresident and CEO2009-05-15Sell5,000353,506$20.12100.637.08
Scott Randal WExecutive Chairman2009-05-12Sell12,0001,946,646$19.46233.5241.73
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-05-11Buy88194,080$19.551.7241.07
Baker / Tisch Capital (GP), LLDirector, 10% Owner2009-05-11Buy312194,071$19.556.141.07
Baker Brothers Life Sciences CDirector, 10% Owner2009-05-11Buy137,4663,629,658$19.552687.4641.07
14159 capital (GP), LLCDirector, 10% Owner2009-05-11Buy3,82798,152$19.5574.8241.07
Baker JoffreChief Scientific Officer2009-05-08Sell4,629187,152$19.7291.2839.86
Scott Randal WExecutive Chairman2009-04-14Sell12,0001,958,646$25.47305.648.28
Baker JoffreChief Scientific Officer2009-04-01Sell4,629191,781$25.27116.979.14
Scott Randal WExecutive Chairman2009-03-11Sell12,0001,970,646$19.4232.842.16
Baker JoffreChief Scientific Officer2009-03-03Sell4,629196,410$19.1388.5544.17
Cole G BradleyCOO & CFO2009-02-17Sell5,0003,000$21.52107.628.16
Baker JoffreChief Scientific Officer2009-02-12Sell4,629201,039$20.695.3633.88
Baker JoffreChief Scientific Officer2009-02-12Sell4,62922,226$20.695.3633.88
Scott Randal WExecutive Chairman, Director2009-02-11Sell12,0001,982,646$20.85250.232.28
Baker JoffreChief Scientific Officer2009-01-12Sell4,62926,855$19.4189.8542.09
Shak StevenChief Medical Officer2008-12-22Sell100413,278$20.172.0236.74
Baker JoffreChief Scientific Officer2008-12-10Sell4,629205,668$19.2589.1143.27
Baker JoffreChief Scientific Officer2008-12-10Sell4,62931,484$19.2589.1143.27
Scott Randal WCEO, Director2008-12-09Sell12,0001,955,298$18.4220.849.89
Baker JoffreChief Scientific Officer2008-11-12Sell4,629210,297$19.8791.9838.8
Baker JoffreChief Scientific Officer2008-11-12Sell4,62936,113$19.8791.9838.8
Scott Randal WCEO, Director2008-11-11Sell12,0001,967,298$20.05240.637.56
Cole G BradleyEVP & CFO2008-11-10Sell10,0004,000$20.17201.736.74
Scott Randal WCEO, Director2008-10-14Sell12,0001,979,298$20.36244.3235.46
Baker JoffreChief Scientific Officer2008-10-01Sell9,25840,742$22.51208.422.52
Shak StevenChief Medical Officer2008-09-24Sell5,000413,378$22.67113.3521.66
Scott Randal WCEO, Director2008-09-16Sell12,0001,991,298$21.79261.4826.57
Shak StevenChief Medical Officer2008-08-26Sell5,000418,378$22.93114.6520.28
Baker JoffreChief Scientific Officer2008-08-26Sell4,629214,926$22.69105.0321.55
Cole G BradleyEVP & CFO2008-08-18Sell9,2984,000$23.67220.0816.52
Popovits Kimberly JPresident and COO2008-08-15Sell25,000358,506$24.2460613.78
Scott Randal WCEO, Director2008-08-12Sell12,0002,003,298$23.76285.1216.08
Scott Randal WCEO, Director2008-07-15Sell12,0002,015,298$2125231.33
Baker JoffreChief Scientific Officer2008-07-01Sell4,629219,555$19.2689.1543.2
Shak StevenChief Medical Officer2008-06-24Sell100423,378$20237.9
Scott Randal WCEO, Director2008-06-10Sell12,0002,027,298$19.92239.0438.45
Baker Brothers Life Sciences CDirector, 10% Owner2008-06-09Buy320,9833,492,192$19.916390.7738.52
Baker Biotech Capital (GP), LLDirector, 10% Owner2008-06-09Buy76,0151,226,119$19.911513.4638.52
14159 capital (GP), LLCDirector, 10% Owner2008-06-09Buy10,29994,325$19.91205.0538.52
Baker JoffreChief Scientific Officer2008-06-02Sell4,629228,813$17.9983.2853.31
Scott Randal WCEO, Director2008-05-13Sell12,0002,039,298$18.7522547.09
Baker JoffreChief Scientific Officer2008-05-08Sell4,629233,442$19.2789.243.12
Scott Randal WCEO, Director2008-04-15Sell12,0002,051,298$17.22206.6460.16
Scott Randal WCEO, Director2008-03-11Sell12,0002,063,298$18.84226.0846.39
Baker JoffreChief Scientific Officer2008-03-05Sell4,629242,700$20.4894.834.67
Shak StevenChief Medical Officer2008-02-26Sell5,000423,478$20.23101.1536.33
Cole G BradleyEVP & CFO2008-02-19Sell9,0008,298$22.58203.2222.14
Scott Randal WCEO, Director2008-02-12Sell12,0002,075,298$23.01276.1219.86
Baker JoffreChief Scientific Officer2008-02-11Sell4,629247,329$22.94106.1920.23
Scott Randal WCEO, Director2008-01-15Sell12,0002,087,298$25.54306.487.99
Baker JoffreChief Scientific Officer2008-01-02Sell4,629251,958$22.66104.8921.71
Baker JoffreChief Scientific Officer2007-12-03Sell4,6290$23.1106.9319.39
Popovits Kimberly JPresident and COO2007-11-27Sell6,655383,506$22146.4125.36
Scott Randal WCEO, Director2007-11-09Sell12,0002,111,299$23.07276.8419.55
Baker JoffreChief Scientific Officer2007-11-08Sell4,629265,845$23.21107.4418.83
Scott Randal WCEO2007-10-09Sell12,0002,123,299$20.16241.9236.81
Baker JoffreChief Scientific Officer2007-10-01Sell4,629270,474$19.8491.8439.01
Scott Randal WCEO, Director2007-09-11Sell12,0002,135,299$19.7236.440
Scott Randal WCEO2007-09-11Sell12,0002,135,299$19.69236.2840.07
Baker JoffreChief Scientific Officer2007-09-10Sell4,629275,103$19.5790.5940.93
Goldberg Michael DDirector2007-08-23Buy5,3505,350$18.76100.3747.01
Scott Randal WCEO2007-08-15Sell12,0002,147,299$19.91238.9238.52
Baker JoffreChief Scientific Officer2007-08-08Sell4,629279,732$19.4489.9941.87
Scott Randal WCEO2007-07-18Sell12,0002,159,299$21.18254.1630.22
Baker JoffreChief Scientific Officer2007-07-02Sell4,629284,361$19.018845.08
Scott Randal WCEO2007-06-19Sell12,0002,171,299$19.16229.9243.95
Baker JoffreChief Scientific Officer2007-06-01Sell4,629288,990$17.5681.2957.06
Baker Bros. Capital (GP), LLCDirector2007-05-30Buy545193,992$16.328.8969
Baker Biotech Capital (GP), LLDirector2007-05-30Buy81,1811,150,104$16.321324.8769
Baker Brothers Life Sciences CDirector2007-05-30Buy214,0993,171,209$16.323494.169
14159 capital (GP), LLCDirector2007-05-30Buy6,80784,026$16.32111.0969
14159 capital (GP), LLCDirector2007-05-24Buy16,26177,219$16.59269.7766.24
Baker Brothers Life Sciences CDirector2007-05-24Buy511,5532,957,110$16.598486.6666.24
Baker Biotech Capital (GP), LLDirector2007-05-24Buy193,9661,068,923$16.593217.966.24
Baker Bros. Capital (GP), LLCDirector2007-05-24Buy1,303193,447$16.5921.6266.24
14159 capital (GP), LLCDirector2007-05-21Buy22,49160,958$15.5348.6177.94
14159 capital (GP), LLCDirector2007-05-21Buy160,958$15.50.0277.94
Baker Brothers Life Sciences CDirector2007-05-21Buy707,4582,445,557$15.510965.677.94
Baker Biotech Capital (GP), LLDirector2007-05-21Buy268,248874,957$15.54157.8477.94
Baker Bros. Capital (GP), LLCDirector2007-05-21Buy1,803192,144$15.527.9577.94
Baker Bros. Capital (GP), LLCDirector2007-05-21Buy1,803192,144$15.527.9577.94
Scott Randal WCEO2007-05-08Sell12,0002,183,299$16.62199.4465.94
Baker JoffreChief Scientific Officer2007-05-08Sell4,629293,619$16.3175.569.1
Scott Randal WCEO2007-04-10Sell12,0002,195,299$17.27207.2459.7
Baker JoffreChief Scientific Officer2007-04-02Sell4,629298,248$17.1679.4360.72
Baker / Tisch Capital (GP), LLDirector2007-03-09Buy3,181193,759$18.2858.1550.88
Baker Bros. Capital (GP), LLCDirector2007-03-09Buy376190,341$18.286.8750.88
Baker Biotech Capital (GP), LLDirector2007-03-09Buy62,325606,709$18.281139.350.88
Baker Brothers Life Sciences CDirector2007-03-09Buy168,5601,738,099$18.283081.2850.88
14159 capital (GP), LLCDirector2007-03-09Buy5,37538,467$18.2898.2650.88
Scott Randal WCEO2007-03-06Sell12,0002,207,299$18.35220.250.3
Baker Bros. Capital (GP), LLCDirector2007-03-02Buy119189,965$18.092.1552.46
14159 capital (GP), LLCDirector2007-03-02Buy1,70733,092$18.0930.8852.46
Baker / Tisch Capital (GP), LLDirector2007-03-02Buy1,072190,578$18.119.452.38
Baker Biotech Capital (GP), LLDirector2007-03-02Buy19,795544,384$18.09358.0952.46
Baker Brothers Life Sciences CDirector2007-03-02Buy53,5331,569,539$18.09968.4152.46
Baker JoffreChief Scientific Officer2007-03-01Sell4,629302,877$18.1884.1651.71
MYERS WOODROW A JRDirector2007-02-21Buy2,00012,000$19.6339.2640.5
Baker Brothers Life Sciences CDirector2007-02-16Buy25,4121,516,006$18.54471.1448.76
Baker Biotech Capital (GP), LLDirector2007-02-16Buy9,396524,589$18.54174.248.76
Baker / Tisch Capital (GP), LLDirector2007-02-16Buy525189,506$18.549.7348.76
14159 capital (GP), LLCDirector2007-02-16Buy81131,385$18.5415.0448.76
Baker Bros. Capital (GP), LLCDirector2007-02-16Buy56189,846$18.541.0448.76
Baker Bros. Capital (GP), LLCDirector2007-02-14Buy579189,790$18.2510.5751.12
Baker / Tisch Capital (GP), LLDirector2007-02-14Buy5,346188,981$18.2597.5651.12
Baker Biotech Capital (GP), LLDirector2007-02-14Buy95,783515,193$18.251748.0451.12
14159 capital (GP), LLCDirector2007-02-14Buy8,25630,574$18.25150.6751.12
Baker Brothers Life Sciences CDirector2007-02-14Buy259,0441,490,594$18.254727.5551.12
Scott Randal WCEO2007-02-13Sell12,0002,219,299$18.12217.4452.21
Baker JoffreChief Scientific Officer2007-02-08Sell4,629307,506$18.9787.8145.39
Baker / Tisch Capital (GP), LLDirector2006-12-06Buy642183,635$21.5813.8527.8
Baker Brothers Life Sciences CDirector2006-12-06Buy34,1731,231,550$21.58737.4527.8
14159 capital (GP), LLCDirector2006-12-06Buy1,12022,318$21.5824.1727.8
Baker Biotech Capital (GP), LLDirector2006-12-06Buy12,237419,410$21.58264.0727.8
MYERS WOODROW A JRDirector2006-12-05Buy10,00010,000$21.97219.725.53
Baker / Tisch Capital (GP), LLDirector2006-12-05Buy9,096182,993$20.6187.3833.88
Baker Biotech Capital (GP), LLDirector2006-12-05Buy173,441407,173$20.63572.8833.88
14159 capital (GP), LLCDirector2006-12-05Buy15,88021,198$20.6327.1333.88
Baker Brothers Life Sciences CDirector2006-12-05Buy484,3331,197,377$20.69977.2633.88
14159 capital (GP), LLCDirector2006-09-08Buy5,3185,318$14.0574.7296.3Link
Baker Biotech Capital (GP), LLDirector2006-09-08Buy75,246233,732$14.051057.2196.3Link
Baker Brothers Life Sciences CDirector2006-09-08Buy237,236713,044$14.053333.1796.3Link
Baker Biotech Capital III (GP)10% Owner2005-10-04Buy136,316252,529$121635.79129.83Link
Baker Biotech Capital II (GP),10% Owner2005-10-04Buy38,684181,478$12464.21129.83Link

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

"Shares" change (fifth column), "Shares Owned Following This (Direct & Indirect)" transactions (sixth column), and "Trade Price ($)" (seventh column) are split adjusted. The "Share Ownership Details" (last column) displayed data is as of reported (also split adjusted).

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK